Dermatology · Wayne, PA
NPI
1447297502
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
995 Old Eagle School Rd, Suite 304-F
Wayne, PA, 19087
Phone (610) 688-3099
Groups this clinician bills Medicare through
Medicare paid, 2024
$280K
6,392 services
Medicare patients, 2024
1,020
Average age 74
Drug cost, 2024
$865K
2,924 prescriptions
Company payments, 2025
$1,666
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David P Manion was code 17003 (destruction skin lesion), 1,696 times for 276 patients. In total David P Manion billed 6,392 services in 49 codes, and Medicare paid $280K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-11-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,696 | 276 | $4.82 | $8,181 |
| 99213 Office E&M - Established | Office | 1,086 | 716 | $59.10 | $64K |
| 17000 Destruction Skin Lesion | Office | 605 | 403 | $28.30 | $17K |
| 11102 Skin Biopsy | Office | 571 | 470 | $56.74 | $32K |
| 17110 Destruction Skin Lesion | Office | 505 | 360 | $75.41 | $38K |
| 99214 Office E&M - Established | Office | 373 | 278 | $85.12 | $32K |
| 96910 Skin | Office | 358 | 13 | $84.02 | $30K |
| 11103 Skin Biopsy | Office | 206 | 151 | $36.10 | $7,437 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 177 | 37 | $0.76 | $134 |
| 99212 Office E&M - Established | Office | 138 | 102 | $36.87 | $5,089 |
| 99203 Office E&M - New | Office | 120 | 120 | $65.26 | $7,831 |
| 11104 Skin Biopsy | Office | 57 | 55 | $80.75 | $4,603 |
| 11901 Skin | Office | 57 | 18 | $47.52 | $2,708 |
| 99204 Office E&M - New | Office | 54 | 54 | $100.86 | $5,447 |
| 11900 Skin | Office | 46 | 25 | $37.13 | $1,708 |
By year: 2022 $262K for 5,986 services; 2023 $272K for 6,400 services; 2024 $280K for 6,392 services.
Medicare prescription drug claims, 2024
In 2024, the drug David P Manion prescribed most often to Medicare patients was Betamethasone Dipropionate, with 366 prescriptions and refills. In total David P Manion wrote 2,924 Medicare prescriptions that cost $865K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Betamethasone Dipropionate Generic | 366 | 405 | 184 | $16K |
| Triamcinolone Acetonide Generic | 346 | 414 | 199 | $4,620 |
| Clobetasol Propionate Generic | 183 | 199 | 83 | $7,308 |
| Mometasone Furoate Generic | 180 | 198 | 129 | $3,840 |
| Ketoconazole Generic | 179 | 190 | 82 | $4,166 |
| Hydrocortisone Generic | 129 | 140 | 99 | $646 |
| Doxycycline Hyclate Generic | 128 | 134 | 78 | $2,306 |
| Betamethasone Valerate Generic | 112 | 123 | 69 | $3,593 |
| Fluocinonide Generic | 109 | 115 | 59 | $5,112 |
| Clindamycin Phosphate Generic | 106 | 116 | 45 | $4,093 |
| Cephalexin Generic | 84 | 84 | 74 | $671 |
| Prednisone Generic | 73 | 73 | 43 | $325 |
| Metronidazole Generic | 68 | 75 | 38 | $3,629 |
| Fluorouracil Generic | 67 | 73 | 65 | $4,792 |
| Silver Sulfadiazine Generic | 63 | 72 | 24 | $1,002 |
Brand drugs: - claims; generic drugs: 2,540 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David P Manion $1,666 ($1,666 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $674.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 50 | $674 |
| Galderma Laboratories, L.P. GALD.SW | 12 | $210 |
| Janssen Biotech, Inc. JNJ | 13 | $200 |
| Genzyme Corporation SNY | 8 | $159 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 9 | $147 |
| Almirall LLC | 2 | $71.95 |
| UCB, Inc. UCB.BR | 1 | $30.75 |
| LEO Pharma Inc. | 1 | $27.25 |
| Lilly USA, LLC LLY | 1 | $24.98 |
| Paratek Pharmaceuticals, Inc. | 1 | $24.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.